Pricing Log in Create free account

Corvus Pharmaceuticals, Inc. (CRVS) vs Latigo Biotherapeutics Inc (LTGO)

Corvus Pharmaceuticals, Inc. and Latigo Biotherapeutics Inc are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Latigo Biotherapeutics Inc are of similar size ($862.6M and $818.5M). Across the 3 metrics below, Latigo Biotherapeutics Inc leads on 2 and Corvus Pharmaceuticals, Inc. on 1.

Valuation

Metric CRVS LTGO Biotechnology median
P/E n/m — 10.60
P/S n/m n/m 9.40
P/B 4.33 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (5.77%) — (32.88%)
Free cash flow yield (4.63%) 0.00% (23.13%)

Profitability

Metric CRVS LTGO Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (35.43%) — (51.96%)
Return on assets (32.93%) — (46.06%)
Return on invested capital (352.49%) 0.00% 0.00%

Growth

Metric CRVS LTGO Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 48.04% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CRVS LTGO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.16 1.15 4.97
Net debt to EBITDA 1.28 — 1.01

Dividend

Metric CRVS LTGO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRVS LTGO Biotechnology median
Market cap 818.50m 862.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack